Guo Jianjun, head of the Sports Medicine Academic Subgroup, leads a discussion on the integrated development of sports and medical and physical health. [Photo/WeChat account of BSC]

The Sports Medicine Academic Subgroup of the Biophysical Society of China (BSC) arranged a seminar on sports pharmacology in Beijing on Oct 25.

The seminar, which is part of the society's series of activities on the integration of sports and medical and physical health, attracted the participation of 65 experts.

Participants exchanged opinions and held discussions on the first draft of a report called being compiled, entitled Sports Pharmacology.

At the seminar, Zhao Zhigang, a director of Beijing Tiantan Hospital, which is affiliated to Capital Medical University, gave a talk on the academic development of sports pharmacology at home and abroad.

Zhao said the increasing number of patients with chronic conditions posed more challenges for both exercise and drug therapies. He said sports pharmacology had emerged from the effects and the profound impact of the alternative uses of the two therapies.

Professor Guo Jianjun, head of the Sports Medicine Academic Subgroup, stressed that the theories and practices of sports pharmacology was a major means to solve clinical problems caused by the interaction of sports and drugs -- as well as to resolve the urgent need for the integration of sports and medical and physical health.

The compiling work for the report Sports Pharmacology is being done by the national technology service group of the China Association for Science and Technology.

It is arranging for top experts in the fields of pharmacy, sports medicine and healthy activities to explain the problems of clinic risks caused by the alternative interaction of exercise and drugs for patients with clinical diseases -- as well as for athletes and sports enthusiasts -- based on their personal experiences and knowledge.

It is a monograph for sports pharmacology with clinical significance.